Approvals for Bevacizumab and Pazopanib Add Options for Advanced Kidney Cancer
Brian Rini: Approvals for Bevacizumab and Pazopanib Add Options for Advanced Kidney Cancer
20100001
2010 Jan 1
Top Stories of 2009
Approvals for Bevacizumab and Pazopanib Add Options for Advanced Kidney Cancer
Top Stories of 2009. 2010 Jan 1
Brian I. Rini, MD, is an Associate Professor of Medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University in Cleveland, Ohio. A Staff member of the Department of Solid Tumor Oncology and Associate Director for Clinical Research at the Cleveland Clinic Taussig Cancer Institute, Dr. Rini’s work focuses on genitourinary malignancies. 1. In your view, which development in kidney cancer that has occurred in 2009 could have the most significant impact on oncology?The...